Kriegelstein M, Marek A. Synthesis of N-acetyl-L-aspartyl-L-glutamic acid; [
3 H]NAAG.
J Labelled Comp Radiopharm 2022;
65:244-253. [PMID:
35840548 DOI:
10.1002/jlcr.3991]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 06/29/2022] [Accepted: 07/13/2022] [Indexed: 11/07/2022]
Abstract
[3 H]NAAG, N-acetyl-L-aspartyl-L-glutamic acid has been widely used as a substrate in glutamate carboxypeptidase II (GCPII) reactions, either to determine the inhibitory constants at 50% inhibition (IC50 ) of novel compounds or to measure GCPII activities in different tissues harvested from various disease models. The importance of [3 H]NAAG, combined with its current commercial unavailability, prompted the development of a reliable eight-step synthetic procedure towards [3 H2 ]NAAG starting from commercially available pyroglutamate. Pure [3 H]NAAG of high molar activity (49.8 Ci/mmol) and desired stereochemistry was isolated in high radiochemical yield (67 mCi) and radiochemical purity (>99%). The identity was confirmed by mass spectrometry and co-injection with unlabeled reference.
Collapse